Abu Dhabi Longevity Clinics: What Current Official Sources Show

Abu Dhabi now has a publicly documented healthy-longevity clinic standard, dated announcements about two named providers, and a wider set of official materials covering professional qualifications, telemedicine, health information, medical products, research, and the Abu Dhabi Global Market. Together, these sources show that “longevity clinic” is no longer only a marketing label in the emirate: the Department of Health – Abu Dhabi (DoH) has published a named clinic standard and has reported specific licensing events.

That official record is meaningful, but bounded. A published standard or a licensing announcement does not demonstrate that a treatment slows aging, extends life, improves healthspan, or produces superior outcomes. It also does not describe every service delivered by a clinic or settle how every official framework applies to a particular activity. This article therefore stays close to what the current sources actually say, with dates attached.

This article summarizes publicly available official sources and dated regulatory-status information. It is not legal or medical advice, and the application of particular rules can depend on the activity, entity and circumstances.

DoH has published a healthy-longevity clinic standard

The clearest official development is the Healthy Longevity Medicine Clinic Standard. The document identifies itself as reference DOH/SD/HLMCS/HCF/V1/2024, Version 1. Its document-control page records publication in October 2024, an effective date in April 2025, and a revision date in September 2025. On the access date for this review, the file remained available through DoH and the DoH standards index continued to provide the official standards context.

The standard describes a Healthy Longevity Medicine Clinic as a specialized healthcare facility and sets out a model that includes assessment, screening, risk profiling, care planning, monitoring, governance, staffing, information management, quality, and reporting. Its stated scope is important because it shows how DoH has formally described this clinic category. This article does not extend that wording into a conclusion about a particular provider or service.

DoH also published a 31 October 2024 announcement about the healthy-longevity standards. The announcement provides dated policy and programme context for the standard. It is evidence that DoH publicly introduced the framework; it is not clinical outcome evidence.

For longevity observers, the practical significance is editorial rather than therapeutic. There is now an official vocabulary and a dated source against which claims about the Abu Dhabi clinic landscape can be checked. That makes it easier to separate documented status from broad promotional language. It does not make “longevity medicine” a proven route to longer life.

DoH has announced licences for two named providers

DoH’s news archive contains two relevant provider announcements that were still available on 25 August 2026.

On 19 November 2024, DoH announced a licence for the Institute for Healthier Living Abu Dhabi, describing it as a specialized Healthy Longevity Medicine Centre. On 30 January 2025, DoH announced a licence for Pura Longevity Clinic.

Those are dated status facts. They establish what DoH publicly reported on those dates. They do not establish the current details of either provider’s licence, the status of every individual service, or the performance of a diagnostic or intervention. They also do not transfer to other providers. A reader should not treat a licence announcement as evidence of rejuvenation, lifespan extension, healthspan extension, treatment safety, or comparative clinical quality.

The announcements are nevertheless useful because they show that the standard was accompanied by named licensing activity. They move the public record beyond general ambition while keeping the evidentiary boundary clear: official status and clinical outcomes are different questions.

Professional qualifications and clinical privileges have separate official sources

The clinic standard sits within a wider healthcare-source landscape. DoH’s current Professional Qualification Requirements page points to the Unified Healthcare Professional Qualification Requirements used by UAE health authorities. DoH also publishes a Standard for Clinical Privileging.

These sources describe different parts of the professional and facility environment. The qualification material addresses recognized professional categories and qualification pathways. The privileging standard describes a facility process for assigning a practitioner’s clinical activities. Their presence is useful context when a clinic markets a wide range of specialist services. This article does not use those documents to decide the position of any named professional or procedure.

The UAE legislation portal’s page for Federal Law No. 5 of 2019 also identifies the federal medical-practice instrument and its official title. The portal is included here as a source locator, not as a basis for individualized advice.

Telemedicine has its own published material

DoH publishes a Telemedicine Standard. Its existence matters because longevity services may combine in-person assessment with remote follow-up, digital coaching, wearables, or consultations across locations.

For this landscape article, the bounded point is simple: telemedicine appears as a separately documented subject in DoH’s official material. A website’s description of a remote service does not, by itself, answer questions about a specific consultation, professional, patient location, prescription, or transfer of records. Those fact patterns are outside this article.

DoH’s data and exchange pages show an evolving technical framework

DoH’s AAMEN page lists the Abu Dhabi Healthcare Information and Cyber Security Standard Version 2, or ADHICS V2. The same page identifies earlier patient-data privacy and internet-of-medical-things standards as retired and addressed in ADHICS V2. That retirement wording is an explicit current-source fact and illustrates why old document lists can become misleading.

DoH also publishes a Health Information Exchange Standards page. On the review date, the page described 2026 data standards for exchange through Malaffi. This shows that the official technical-source landscape continues to be updated.

These pages are relevant to a sector that can generate laboratory, imaging, genomic, wearable, questionnaire, and longitudinal clinical data. They do not support a conclusion about where a particular dataset should be stored, whether a specific transfer can occur, or which role a specific organization occupies. The factual takeaway is that current DoH security and exchange materials exist, carry versions or dates, and can replace older documents.

The UAE legislation portal also identifies Federal Law No. 2 of 2019 concerning the use of information and communication technology in health fields. Here again, the link is a primary official locator. This article does not interpret its application to a particular data flow.

Medical products and health advertising are part of a changing service landscape

The UAE legislation portal identifies Federal Decree-Law No. 38 of 2024 governing medical products, pharmacists and pharmaceutical establishments. The portal records an issued date of 1 October 2024 and an effective date of 2 January 2025.

MOHAP’s current service-transfer notice says that selected services moved to the Emirates Drug Establishment (EDE). Its published lists include product-related marketing approvals and distinguish services transferred fully, transferred in part, or retained by MOHAP. The notice also distinguishes health-advertisement services connected with medical products from other categories.

This is a dated institutional development, not a decision tree for a hypothetical clinic or advertiser. The source shows why an old sentence that assigns all health-advertising activity to a single authority can become stale. The correct editorial approach is to identify the current official service pages and their dates, then avoid guessing how a mixed service or campaign would be handled.

ADGM publishes healthcare and data-protection materials

Abu Dhabi Global Market (ADGM) maintains its own official material. In a January 2023 announcement, ADGM described its Healthcare Regulations 2022 and the respective roles it said ADGM’s Registration Authority and DoH would hold for healthcare operators in ADGM.

ADGM also announced its Data Protection Regulations 2021. Its Office of Data Protection guidance page lists guidance on topics such as processing principles, individual rights, security, impact assessments, breaches, and transfers. In September 2025, ADGM announced Substantial Public Interest Rules under the 2021 regulations.

The bounded observation is that an ADGM connection can introduce additional official materials for consideration. This article does not decide whether ADGM material applies to a particular clinic, whether one framework takes priority over another, or how an individual data-processing arrangement should be assessed.

DoH publishes research-governance materials

DoH’s official site includes a DoH Institutional Review Board Research Registry. Its presence documents a formal research-governance source and a central registry for studies reviewed by the DoH IRB.

That fact does not classify a particular longevity service as routine care, research, experimental treatment, innovation, quality improvement, or compassionate use. Those labels depend on details not supplied by a general public article. The useful reader takeaway is narrower: research governance has its own official source base and should not be inferred from marketing language.

What the official-source record does not establish

The current official record establishes that DoH published a named standard, made dated announcements about two providers, and maintains related healthcare materials. It does not establish:

• that a longevity intervention slows aging or extends lifespan or healthspan;
• that every service marketed by a named provider has the same status as the facility announcement;
• that a standard or licence announcement covers the whole market;
• that a particular clinic has met every current official condition;
• that every commercial model falls within the same official framework;
• that Abu Dhabi operates a formal “regulatory sandbox” for longevity clinics;
• that a clinic, product, test, programme, or investment has medical or commercial merit.

These distinctions matter because longevity marketing often moves quickly from institutional status to clinical implication. The evidence does not permit that jump. A standard can organize a field without validating every intervention offered within it. A provider announcement can document status without measuring outcomes. An active policy environment can attract investment without establishing therapeutic value.

Why the dates matter

The source set spans documents and announcements from 2019 through 2026. It also contains direct evidence of change: DoH labels some older data materials as retired and addressed in ADHICS V2; the HIE page describes 2026 standards; MOHAP describes a transfer of selected services to EDE; and ADGM added 2025 rules to its data-protection materials.

For that reason, every important status statement in this record is paired with a source date, version, or access date where available. A link alone is not enough. Pages move, service allocations change, standards are revised, and an announcement remains evidence of what was announced on its date—not a perpetual guarantee of later details.

The most defensible conclusion is also the most useful: Abu Dhabi has a visible, documented healthy-longevity clinic framework and named provider announcements, surrounded by a wider official healthcare-source landscape. Readers can use that record to distinguish public status from clinical evidence. They should not use it as a shortcut to a legal, medical, or investment judgment.